Impact of the Systematic Use of the Criteria STOPP/START in Short Stay Geriatric.

Lille Catholic University65 enrolled

Overview

Assess the impact of the systematic use of STOPP/START tool during medication conciliation on the evolution of hospitalised elderly people's quality of life at 2 months.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

Conditions

Quality of Life Drug Use

Interventions

STOPP/START criteriaPROCEDURE

software which helps to do the drug reconciliation

Eligibility

Sex: ALLMin age: 75 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient with more than 75 years old * Hospitalized in geriatrics short-stay * Patient with a written informed consent * Patient with a social security scheme Exclusion Criteria: * Severe dementia * Not able to respond to SF-12 * Disease at final stage * Patient under legal protection (maintenance of justice, tutelage, legal guardianship)

Locations (1)

Hôpital La Porte Verte

Versailles, France

Outcomes

Primary Outcomes

SF-12 Quality of life scale

The evolution of the hospitalised elderly people's quality of life at 2 months will be measured by the SF-12 scale.

Time frame: at inclusion and at 2 months

Secondary Outcomes

Number of falls

The number of falls during the two months following the inclusion will be collected for each patient.

Time frame: at 2 months

Proportion of patients rehospitalized

The proportion of patients that have been rehospitalized (unscheduled hospitalization) during the two months following inclusion will be measured.

Time frame: at 2 months

Mortality

The mortality during the two months following inclusion will be measured.

Time frame: at 2 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.